Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
- PMID: 25339441
- PMCID: PMC4226127
- DOI: 10.1073/pnas.1404656111
Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing
Abstract
The acute cellular response to stress generates a subpopulation of reversibly stress-tolerant cells under conditions that are lethal to the majority of the population. Stress tolerance is attributed to heterogeneity of gene expression within the population to ensure survival of a minority. We performed whole transcriptome sequencing analyses of metastatic human breast cancer cells subjected to the chemotherapeutic agent paclitaxel at the single-cell and population levels. Here we show that specific transcriptional programs are enacted within untreated, stressed, and drug-tolerant cell groups while generating high heterogeneity between single cells within and between groups. We further demonstrate that drug-tolerant cells contain specific RNA variants residing in genes involved in microtubule organization and stabilization, as well as cell adhesion and cell surface signaling. In addition, the gene expression profile of drug-tolerant cells is similar to that of untreated cells within a few doublings. Thus, single-cell analyses reveal the dynamics of the stress response in terms of cell-specific RNA variants driving heterogeneity, the survival of a minority population through generation of specific RNA variants, and the efficient reconversion of stress-tolerant cells back to normalcy.
Keywords: RNA-Seq; drug resistance; paclitaxel; single cell; tumor heterogeniety.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                 
              
              
              
              
                
                
                References
- 
    - Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. - PubMed
 
- 
    - Bock C, Lengauer T. Managing drug resistance in cancer: Lessons from HIV therapy. Nat Rev Cancer. 2012;12(7):494–501. - PubMed
 
- 
    - Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53:615–627. - PubMed
 
- 
    - Mardis ER. A decade’s perspective on DNA sequencing technology. Nature. 2011;470(7333):198–203. - PubMed
 
- 
    - Kan Z, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature. 2010;466(7308):869–873. - PubMed
 
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
 
        